North Texas News

Washington, D.C. – Congressman Michael C. Burgess, M.D. (R-TX), Vice Chairman of the House Rules Committee and Chairman of the House Budget Committee Health Care Task Force, has emphasized the importance of addressing the rising health care costs in the United States. In an op-ed for The Washington Times, Congressman Burgess highlights the inaugural meeting of the Health Care Task Force, which aims to tackle the issue of health care spending and its impact on the nation's budget.

With health care accounting for nearly one-third of the $6.4 trillion in federal government spending this year, it is imperative for Congress to take action in order to control these costs. Congressman Burgess points out that American families are already tightening their belts and finding ways to manage their finances, and it is time for the federal government to do the same.

One of the issues being considered by the Health Care Task Force is the Inflation Reduction Act's (IRA) Medicare drug price control scheme. Congressman Burgess expresses concern over the profound impact this scheme has had on medical innovation, with fewer life-saving medications reaching patients. Independent analyses suggest that more patients may be denied access to vital medicines, and some drug manufacturers have already halted innovative research and development.

The Health Care Task Force recognizes the importance of addressing these issues at the federal level. Congressman Burgess states that this platform will spark constructive dialogue and guide the federal government towards a more accurate and intentional approach to health care spending. He emphasizes that while the financial aspect is significant, this effort is ultimately about shaping the future of health care and ensuring the well-being of American patients.

In conclusion, Congressman Michael C. Burgess, M.D. and the House Budget Committee Health Care Task Force are taking a proactive approach to tackle the rising health care costs in the United States. With a focus on controlling spending and addressing issues such as the Medicare drug price control scheme, they aim to shape the future of health care and prioritize the well-being of American patients.

Click this link to access more information: https://burgess.house.gov/news/documentsingle.aspx?DocumentID=403813